Countries warned against ‘hoarding’ as headway is made towards vaccine

Based on current projections, Pfizer Inc. and BioNTech SE said they expect to produce up to 50 million doses of their BNT162b2, an mRNA-based vaccine candidate against Covid-19, in 2020 and up to 1.3 billion doses in 2021 . / Internet photo
Based on current projections, Pfizer Inc. and BioNTech SE said they expect to produce up to 50 million doses of their BNT162b2, an mRNA-based vaccine candidate against Covid-19, in 2020 and up to 1.3 billion doses in 2021 . / Internet photo
Emmanuel Ntirenganya